Active Constituents: Pantoprazole 40 mg per tablet. Jerdazolin indicated for adults and adolescents 12 years of age and above in:

• Reflux oesophagitis.
• Eradication of H. pylori.
• Gastric ulcer.
• Duodenal ulcer.
• Zollinger-Ellison-Syndrome.

Dosage & Adminstration

• in Reflux oesophagitis, Jerdazolin 40mg, Once daily, for 4-weeks.
• in Eradication of H. pylori., Jerdazolin 40mg, twice daily, for 2-weeks.
• in Gastric ulcer, Jerdazolin 40mg, once daily, for 4 to 8-weeks.
• in Duodenal ulcer, Jerdazolin 40mg, Once daily, for  2 to 4-weeks.
• in Zollinger-Ellison-Syndrome, Jerdazolin 40mg, twice daily, for unlimmited duration.

Key Benefits

• Significantly faster first-time relief from daytime and night-time GERD-related symptoms than esomeprazole.
• Superior to ranitidine (150 mg twice daily) in maintaining erosive oesophagitis healing.
• Useful as a component of first-line triple therapy for H. pylori eradication.
• Effective in the prevention of peptic ulcers in patients with rheumatic diseases.
• Suitable for long term maintenance theory.

Competitive Advantages

• High raw material quality.
• Following the International quality standards.
• Good manufacturing practice (GMP).
• More effective and fast to control hyperacidity symptoms.
• Jerdazoline 40mg can be used safely with patient taking antiplatelet.
• Jerdazoline once daily dose.
• Package & Price: 2 strips for 44 L.E. Each strip contains 7 tablets.

Our goal is to provide you with the most relevant and up-to-date information. However, because pharmaceutical products affect each person differently, we cannot guarantee that this article includes all the information you should know, and you should always consult your doctor, pharmacist or health provider. Copyright: “All rights reserved (c) pharmacia1 .com” – Contact us via the contact form, or simply write a comment at the bottom of the page. ATC code: A02BC02 .